BELLEVUE ASSET MANAGEMENT, LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.

Quarter-by-quarter ownership
BELLEVUE ASSET MANAGEMENT, LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$3,0000.0%29
+52.6%
0.00%0.0%
Q2 2021$3,000
+50.0%
19
-9.5%
0.00%
+100.0%
Q1 2021$2,000
-33.3%
21
-12.5%
0.00%
-50.0%
Q4 2020$3,000
+50.0%
24
+4.3%
0.00%
+100.0%
Q3 2020$2,000
-50.0%
230.0%0.00%
-75.0%
Q2 2020$4,0000.0%230.0%0.00%0.0%
Q1 2020$4,000
+100.0%
23
+130.0%
0.00%
+100.0%
Q4 2019$2,000100.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders